5,530
Views
341
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

Magnetic nanoparticle hyperthermia for prostate cancer

, MD, PhD, FEBU, , &
Pages 790-795 | Received 24 Jan 2010, Accepted 03 Mar 2010, Published online: 23 Jul 2010

References

  • Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002; 3: 487–497
  • Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002; 43: 33–56
  • Stauffer PR. Evolving technology for thermal therapy of cancer. Int J Hyperthermia 2005; 21: 731–744
  • Hartman KB, Wilson LJ, Rosenblum MG. Detecting and treating cancer with nanotechnology. Mol Diagn Ther 2008; 12: 1–14
  • Pankhurst QA, Thanh NKT, Jones SK, Dobson J. Progress in applications of magnetic nanoparticles in biomedicine. J Phys D: Appl Phys 2009; 42: 224001
  • Van Vulpen M, De Leeuw AA, Raaymakers BW, Van Moorselaar RJ, Hofman P, Lagendijk JJ, Battermann JJ. Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: Preliminary results. BJU Int 2004; 93: 36–41
  • Anscher MS, Samulski TV, Dodge R, Prosnitz LR, Dewhirst MW. Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1997; 37: 1059–1065
  • Hurwitz MD, Kaplan ID, Hansen JL, Prokopios-Davos S, Topulos GP, Wishnow K, Manola J, Bornstein BA, Hynynen K. Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile. Int J Hyperthermia 2005; 21: 649–656
  • Algan O, Fosmire H, Hynynen K, Dalkin B, Cui H, Drach G, Stea B, Cassady JR. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma. Cancer 2000; 89: 399–403
  • Kalapurakal JA, Pierce M, Chen A, Sathiaseelan V. Efficacy of irradiation and external hyperthermia in locally advanced, hormone-refractory or radiation recurrent prostate cancer: A preliminary report. Int J Radiat Oncol Biol Phys 2003; 57: 654–664
  • Tilly W, Gellermann J, Graf R, Hildebrandt B, Weissbach L, Budach V, Felix R, Wust P. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlenther Onkol 2005; 181: 35–41
  • Deger S, Bohmer D, Turk I, Roigas J, Budach V, Loening SA. Interstitial hyperthermia using self regulating thermoseeds combined with conformal radiotherapy. Eur Urol 2002; 42: 147–153
  • Maluta S, Dallòglio S, Romano M, Marciai N, Pioli F, Giri MG, Benecchi PL, Comunale L, Porcaro AB. Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: Preliminary results of a prospective phase II study. Int J Hyperthermia 2007; 23: 451–456
  • Ryu S, Brown SL, Khil MS, Kim SH, Kim JH. Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia. Int J Radiat Oncol Biol Phys 1996; 34: 133–138
  • Jordan A, Maier-Hauff K, Wust P, Johannsen M. Nanoparticles for thermotherapy. Nanomaterials for cancer therapy, CSSR Kumar. Wiley-VCH, Weinheim 2006; 242–258
  • Jordan A, Scholz R, Wust P, Fähling H, Wust P. Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magn Magn Mater 1999; 201: 413–419
  • Jordan A, Wust P, Fähling H, John W, Hinz A, Felix R. Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int J Hyperthermia 1993; 9: 51–68
  • Jordan A, Wust P, Scholz R, Tesche B, Fähling H, Mitrovics T, Vogl T, Cervos-Navarro J, Felix R. Cellular uptake of magnetic fluid particles and their effects in AC magnetic fields on human adenocarcinoma cells in vitro. Int J Hyperthermia 1996; 12: 705–722
  • Jordan A, Scholz R, Wust P, Schirra H, Schiestel T, Schmidt H, Felix R. Differential endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro. J Magn Magn Mater 1999; 194: 185–196
  • Jordan A, Scholz R, Maier-Hauff K, Johannsen M, Wust P, Nadobny J, Schirra H, Schmidt H, Deger S, Loening SA, et al. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J Magn Magn Mater 2001; 225: 118–126
  • Jordan A, Wust P, Scholz R, Mitrovics T, Fähling H, Gellermann J, Vogl T, Cervos-Navarro J, Felix R. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo. Int J Hyperthermia 1997; 13: 587–605
  • Jordan A, Scholz R, Maier-Hauff K, Van Landeghem FKH, Waldöfner N, Teichgräber U, Pinkernelle J, Bruhn H, Neumann F, Thiesen B, et al. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neurooncol. 2006; 78: 7–14
  • Johannsen M, Jordan A, Scholz R, Lein M, Koch M, Deger S, Roigas J, Jung K, Loening SA. Evaluation of magnetic fluid hyperthermia in a standard rat model of prostate cancer. J Endourol 2004; 18: 495–500
  • Johannsen M, Thiesen B, Jordan A, Taymoorian K, Gneveckow U, Waldöfner N, Scholz R, Koch M, Lein M, Jung K, et al. Magnetic fluid hyperthermia (MFH) reduces prostate cancer growth in the orthotopic Dunning R3327 rat model. Prostate 2005; 64: 283–292
  • Johannsen M, Thiesen B, Gneveckow U, Taymoorian K, Waldöfner N, Scholz R, Deger S, Jung K, Loening SA, Jordan A. Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer. Prostate 2006; 66: 97–104
  • Johannsen M, Gneveckow U, Eckelt L, Feussner A, Waldöfner N, Scholz R, Deger S, Wust P, Loening SA, Jordan A. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique. Int J Hyperthermia 2005; 21: 637–647
  • Johannsen M, Gneveckow U, Thiesen B, Taymoorian K, Cho CH, Waldöfner N, Scholz R, Jordan A, Loening SA, Wust P. Thermotherapy of prostate cancer using magnetic nanoparticles: Feasibility, imaging and three-dimensional temperature distribution. Eur Urol 2007; 52: 1653–1661
  • Johannsen M, Gneveckow U, Taymoorian K, Thiesen B, Waldöfner N, Scholz R, Jung K, Jordan A, Wust P, Loening SA. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial. Int J Hyperther 2007; 23: 315–323
  • Wust P, Gneveckow U, Johannsen M, Böhmer D, Henkel T, Kahmann F, Sehouli J, Felix R, Ricke J, Jordan A. Magnetic nanoparticles for interstitial thermotherapy – Feasibility, tolerance and achieved temperatures. Int J Hyperthermia 2006; 22: 673–685
  • Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, Feussner A, Von Deimling A, Waldöfner N, Felix R, et al. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: Results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol 2007; 81: 53–60
  • Kampinga HH, Dikomey E. Hyperthermic radiosensitization: Mode of action and clinical relevance. Int J Radiat Biol 2001; 77: 399–408
  • Armour EP, Raaphorst GP. Long duration mild temperature hyperthermia and brachytherapy. Int J Hyperthermia 2004; 20: 175–89

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.